Role of Stereotactic Ablative Radiotherapy in Early-Stage Lung Cancer

In this video Alexander Louie, MD, PhD, MSc, of the London Health Sciences Centre in Canada, discusses the role of stereotactic ablative radiotherapy (SABR) in early-stage lung cancer patients who are not eligible for surgery, some of the literature about late effects of radiotherapy, and data comparing SABR vs surgery.

Louie gave a presentation on this topic at the 2017 Multidisciplinary Thoracic Cancers Symposium.